Laser-assisted in situ keratomileusis complications in diabetes mellitus

Frederick W. Fraunfelder, Larry F. Rich

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Purpose. To report the incidence of complications and the refractive results in patients with diabetes mellitus treated with laser-assisted in situ keratomileusis (LASIK). Methods. A retrospective review of the charts, focusing on 6-month postoperative data, was performed on 30 eyes from patients with diabetes and 150 age- and gender-matched control eyes operated on during the same period. The incidence of complications and postoperative refractive results were compared. The data analyzed include UCVA, spherical equivalent, astigmatism power, astigmatism axis, and vector astigmatism change. Results. Diabetic eyes treated with LASIK had an overall complication rate of 47% compared with the control population complication incidence of 6.9% (p <0.01). The most frequent complications occurring in the diabetic population are punctate epithelial erosions and persistent epithelial defects. Spherical correction change was -4.64 diopters (D) for diabetic eyes and -4.98 D for control eyes (p = 0.49). Mean spherical equivalent change was -4.69 D for diabetic eyes and -4.75 D for control eyes (p = 0.9). Mean change in uncorrected visual acuity (LogMAR) was 1.5 for diabetic eyes and 1.65 for control eyes (p = 0.18). Mean astigmatism magnitude change was 0.31 in diabetic eyes and 0.57 in control eyes (p = 0.12). Mean vector corrected astigmatism change was 0.97 for diabetic eyes and 1.12 for control eyes (p = 0.31). Mean vector-corrected astigmatism axis for patients with diabetes was 18.17 for diabetic eyes and 6.20 for control eyes (p = 0.30). Conclusion. Patients with diabetes who undergo LASIK are at a significantly higher risk of developing postoperative epithelial complications. In addition, this study revealed poorer refractive results in the eyes of patients with diabetes treated with LASIK.

Original languageEnglish (US)
Pages (from-to)246-248
Number of pages3
JournalCornea
Volume21
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Laser In Situ Keratomileusis
Diabetes Complications
Astigmatism
Incidence

Keywords

  • Complications
  • Cornea
  • Diabetes mellitus
  • Keratopathy
  • Laser-assisted in situ keratomileusis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Laser-assisted in situ keratomileusis complications in diabetes mellitus. / Fraunfelder, Frederick W.; Rich, Larry F.

In: Cornea, Vol. 21, No. 3, 2002, p. 246-248.

Research output: Contribution to journalArticle

Fraunfelder, Frederick W. ; Rich, Larry F. / Laser-assisted in situ keratomileusis complications in diabetes mellitus. In: Cornea. 2002 ; Vol. 21, No. 3. pp. 246-248.
@article{afe63df592694ab5bf034f6874715563,
title = "Laser-assisted in situ keratomileusis complications in diabetes mellitus",
abstract = "Purpose. To report the incidence of complications and the refractive results in patients with diabetes mellitus treated with laser-assisted in situ keratomileusis (LASIK). Methods. A retrospective review of the charts, focusing on 6-month postoperative data, was performed on 30 eyes from patients with diabetes and 150 age- and gender-matched control eyes operated on during the same period. The incidence of complications and postoperative refractive results were compared. The data analyzed include UCVA, spherical equivalent, astigmatism power, astigmatism axis, and vector astigmatism change. Results. Diabetic eyes treated with LASIK had an overall complication rate of 47{\%} compared with the control population complication incidence of 6.9{\%} (p <0.01). The most frequent complications occurring in the diabetic population are punctate epithelial erosions and persistent epithelial defects. Spherical correction change was -4.64 diopters (D) for diabetic eyes and -4.98 D for control eyes (p = 0.49). Mean spherical equivalent change was -4.69 D for diabetic eyes and -4.75 D for control eyes (p = 0.9). Mean change in uncorrected visual acuity (LogMAR) was 1.5 for diabetic eyes and 1.65 for control eyes (p = 0.18). Mean astigmatism magnitude change was 0.31 in diabetic eyes and 0.57 in control eyes (p = 0.12). Mean vector corrected astigmatism change was 0.97 for diabetic eyes and 1.12 for control eyes (p = 0.31). Mean vector-corrected astigmatism axis for patients with diabetes was 18.17 for diabetic eyes and 6.20 for control eyes (p = 0.30). Conclusion. Patients with diabetes who undergo LASIK are at a significantly higher risk of developing postoperative epithelial complications. In addition, this study revealed poorer refractive results in the eyes of patients with diabetes treated with LASIK.",
keywords = "Complications, Cornea, Diabetes mellitus, Keratopathy, Laser-assisted in situ keratomileusis",
author = "Fraunfelder, {Frederick W.} and Rich, {Larry F.}",
year = "2002",
doi = "10.1097/00003226-200204000-00002",
language = "English (US)",
volume = "21",
pages = "246--248",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Laser-assisted in situ keratomileusis complications in diabetes mellitus

AU - Fraunfelder, Frederick W.

AU - Rich, Larry F.

PY - 2002

Y1 - 2002

N2 - Purpose. To report the incidence of complications and the refractive results in patients with diabetes mellitus treated with laser-assisted in situ keratomileusis (LASIK). Methods. A retrospective review of the charts, focusing on 6-month postoperative data, was performed on 30 eyes from patients with diabetes and 150 age- and gender-matched control eyes operated on during the same period. The incidence of complications and postoperative refractive results were compared. The data analyzed include UCVA, spherical equivalent, astigmatism power, astigmatism axis, and vector astigmatism change. Results. Diabetic eyes treated with LASIK had an overall complication rate of 47% compared with the control population complication incidence of 6.9% (p <0.01). The most frequent complications occurring in the diabetic population are punctate epithelial erosions and persistent epithelial defects. Spherical correction change was -4.64 diopters (D) for diabetic eyes and -4.98 D for control eyes (p = 0.49). Mean spherical equivalent change was -4.69 D for diabetic eyes and -4.75 D for control eyes (p = 0.9). Mean change in uncorrected visual acuity (LogMAR) was 1.5 for diabetic eyes and 1.65 for control eyes (p = 0.18). Mean astigmatism magnitude change was 0.31 in diabetic eyes and 0.57 in control eyes (p = 0.12). Mean vector corrected astigmatism change was 0.97 for diabetic eyes and 1.12 for control eyes (p = 0.31). Mean vector-corrected astigmatism axis for patients with diabetes was 18.17 for diabetic eyes and 6.20 for control eyes (p = 0.30). Conclusion. Patients with diabetes who undergo LASIK are at a significantly higher risk of developing postoperative epithelial complications. In addition, this study revealed poorer refractive results in the eyes of patients with diabetes treated with LASIK.

AB - Purpose. To report the incidence of complications and the refractive results in patients with diabetes mellitus treated with laser-assisted in situ keratomileusis (LASIK). Methods. A retrospective review of the charts, focusing on 6-month postoperative data, was performed on 30 eyes from patients with diabetes and 150 age- and gender-matched control eyes operated on during the same period. The incidence of complications and postoperative refractive results were compared. The data analyzed include UCVA, spherical equivalent, astigmatism power, astigmatism axis, and vector astigmatism change. Results. Diabetic eyes treated with LASIK had an overall complication rate of 47% compared with the control population complication incidence of 6.9% (p <0.01). The most frequent complications occurring in the diabetic population are punctate epithelial erosions and persistent epithelial defects. Spherical correction change was -4.64 diopters (D) for diabetic eyes and -4.98 D for control eyes (p = 0.49). Mean spherical equivalent change was -4.69 D for diabetic eyes and -4.75 D for control eyes (p = 0.9). Mean change in uncorrected visual acuity (LogMAR) was 1.5 for diabetic eyes and 1.65 for control eyes (p = 0.18). Mean astigmatism magnitude change was 0.31 in diabetic eyes and 0.57 in control eyes (p = 0.12). Mean vector corrected astigmatism change was 0.97 for diabetic eyes and 1.12 for control eyes (p = 0.31). Mean vector-corrected astigmatism axis for patients with diabetes was 18.17 for diabetic eyes and 6.20 for control eyes (p = 0.30). Conclusion. Patients with diabetes who undergo LASIK are at a significantly higher risk of developing postoperative epithelial complications. In addition, this study revealed poorer refractive results in the eyes of patients with diabetes treated with LASIK.

KW - Complications

KW - Cornea

KW - Diabetes mellitus

KW - Keratopathy

KW - Laser-assisted in situ keratomileusis

UR - http://www.scopus.com/inward/record.url?scp=0036194003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036194003&partnerID=8YFLogxK

U2 - 10.1097/00003226-200204000-00002

DO - 10.1097/00003226-200204000-00002

M3 - Article

C2 - 11917170

AN - SCOPUS:0036194003

VL - 21

SP - 246

EP - 248

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 3

ER -